Navigation Links
Elcelyx Therapeutics Completes $20 Million Series C Financing to Advance NewMet and Lovidia
Date:2/14/2013

SAN DIEGO, Feb. 14, 2013 /PRNewswire/ -- Elcelyx Therapeutics announced today the closing of a $20 million Series C financing to fund development of product candidates NewMet™ for Type 2 diabetes and Lovidia™, an over-the-counter weight loss product. The financing was led by GSM Fund LLC, a fund dedicated to this single investment and managed by Rick Barry , who has been elected to the Elcelyx Board of Directors. All previous investors also participated in the round, including Morgenthaler Ventures, Kleiner Perkins Caufield & Byers, and Technology Partners.

Elcelyx has raised a total of $43 million since it was founded in 2010 and advanced its two first-in-class Gut Sensory Modulators (GSM) for the treatment of diabetes and weight loss into late-stage clinical development.

Pharmaceutical product candidate NewMet is a delayed-release formulation of generic metformin, the #1 diabetes product in the world. By targeting this GSM to the lower gut and avoiding systemic absorption, NewMet is designed to have low bioavailability with preserved efficacy. In a recently completed Phase 2a clinical study in patients with Type 2 diabetes, NewMet met the primary endpoint of lowered glucose and demonstrated improved tolerability compared to generic metformin.

Lovidia, a proprietary mix of Generally Recognized As Safe (GRAS)-designated dietary ingredients, is targeted to the consumer market. Lovidia can be used for multiple applications including as an over-the-counter product for weight loss and metabolic health, and as a food additive for satiety and lower glycemic index. An early version of Lovidia demonstrated statistically significant progressive and sustained weight
'/>"/>

SOURCE Elcelyx Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Elcelyx Therapeutics Names Mark Wiggins Senior Vice President of Business Development, Ginger Graham to Board of Directors
2. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
3. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
4. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
5. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
6. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
7. Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland
8. Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
9. Cara Therapeutics Licenses Novel Kappa Opioid Agonist, CR845, to Chong Kun Dang Pharmaceutical Corporation For South Korean Market
10. Frost & Sullivan: High Uptake of New Drug Therapies and Aging Population Expansion Keep the U.S. Retinal Therapeutics Market Buoyant
11. Zenobia Therapeutics, Inc. And BioBlocks, Inc. Announce Sale Of A Joint Fragment Library Ideal For Screening By All Popular Methods
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... 2013  Regulatory and marketplace changes have pushed ... priority list. Forward-thinking companies across ... strong Medical Affairs function is essential ... market education , and regulatory compliance. These areas ... between an organization and one of the most ...
(Date:5/24/2013)... , May 24, 2013  BD (Becton, Dickinson and Company) ... company, announced today that it will present at the Deutsche ... May 30, 2013, at 10:40 a.m. (ET). ... the BD corporate website at www.bd.com/investors and will ... About BD BD is a leading ...
(Date:5/24/2013)... , May 24, 2013 /PRNewswire-iReach/ -- Phoenix Houses ... non-profit substance abuse services organization, is hosting its tenth ... Hills Hotel on June 6, 2013.  More than 300 ... funds for the adolescent residential treatment centers, family therapy, ... honor individuals whose accomplishments have positive influences on the ...
Breaking Medicine Technology:Building Medical Affairs Capabilities to Ensure Organizational Success across Key Operational Areas 2Phoenix House Honors Allergan Chairman David Pyott And Legendary Sports Agent And Humanitarian, Leigh Steinberg 2Phoenix House Honors Allergan Chairman David Pyott And Legendary Sports Agent And Humanitarian, Leigh Steinberg 3
... Inc., a pharmaceutical company developing orally-available antiviral therapeutics to ... President and Chief Executive Officer, will present at the ... March 8, 2011, 1:30 pm ET, at the Boston ... Company Health Care Conference is a conference for institutional ...
... Advanstar Communications, Inc., a leading worldwide ... Life Sciences and Powersports industries, announced today that it ... position of Executive Vice President, Pharmaceutical/Science. With ... Chief Administrative Officer roles, this new position is another ...
Cached Medicine Technology:Chimerix to Present at Cowen and Company 31st Annual Health Care Conference 2Chimerix to Present at Cowen and Company 31st Annual Health Care Conference 3Veteran Executive Ron Wall Joins Advanstar Communications as Executive Vice President, Pharmaceutical/Science 2
(Date:5/24/2013)... Atlanta, GA (PRWEB) May 24, 2013 Started ... convention held in Orlando. 2013 marks AMTC’s 31st anniversary. ... same family, starting with supermodel Millie Lewis and her daughter, ... by top agents, managers, casting directors, and music professionals including ... Dramatic Arts and XP Media. They are kings of Hollywood ...
(Date:5/24/2013)... May 24, 2013 Amirsys today announces ... new enhancements for instructors and students. Instructors can use ... through personalize learning plan templates, targeted reading assignments, and ... 500 new assessment questions, 5,000 searchable anatomy glossary terms, ... AnatomyOne 2.0 is the first gross anatomy ...
(Date:5/24/2013)... New York, NY (PRWEB) May 24, 2013 ... of Yahoo Commerce VP, Brandon Huff as Executive Vice ... ran its commerce business units, which represented a large ... will lead digital growth as Dwell develops a fully-integrated ... him a decade of experience monetizing digital content for ...
(Date:5/24/2013)... 24 (HealthDay News) -- Low-income, minority parents have ... and are more open to vaccinating their daughters ... small new study contends. Conversely, white, middle-class ... for their daughters, according to researchers from the ... Americans will get an HPV-related cancer each year, ...
(Date:5/24/2013)... Bethesda, MD (PRWEB) May 24, 2013 ... to its growing base of clients. As a result ... reports a presence in 20 states around the ... providing medical transcription services to the healthcare industry ... nurses who use their years of clinical work ...
Breaking Medicine News(10 mins):Health News:AMTC’s Summer SHINE Event Coming to Orlando’s Luxurious Gaylord Palms July 2-7, 2013 2Health News:Amirsys AnatomyOne 2.0 Delivers Personalized Learning Plans 2Health News:Yahoo Commerce Head Joins Leadership at Dwell Media 2Health News:Low-Income, Minority Parents More Open to HPV Vaccine for Girls, Study Says 2Health News:The Dictation Source Signs Two National Hospital Chains 2Health News:The Dictation Source Signs Two National Hospital Chains 3
... CoLucid Pharmaceuticals, Inc., an,innovative biotechnology company ... announced it closed a $25 million Series ... round, which included previous investors,Pappas Ventures, Domain ... Ventures. The financing will be used to ...
... subjective decision-making , ... Los Angeles (PRWEB) July 1, ... their patients who have a heart abnormality called myocardial bridging and ... Cedars-Sinai Medical Center, the University of Texas Medical Branch and RWTH ...
... and the first day of summer is upon us, the cancer care ... the sun when spending time outdoors. Although the most prevalent cancer in ... majority of the more than 1 million annual U.S. cases of skin ... ...
... have developed a series of tests that for the first ... smell (olfactory function) in young children, according to a new ... Head and Neck Surgery . , The study, authored ... can identify a majority of 16 different test odorants that ...
... Center, Atlanta, Georgia, "Elimination of Health ... Professionals", WASHINGTON, July 1 The ... Association:, WHAT: The nation,s largest and ... minority and underserved populations, the National,Medical Association ...
... TITUSVILLE, N.J., June 30 Janssen, Division,of Ortho-McNeil-Janssen ... generic version of RISPERDAL(R) (risperidone),through Patriot Pharmaceuticals, L.L.C., ... companies are a part of the,Johnson & Johnson ... it will continue to make available branded,RISPERDAL, which ...
Cached Medicine News:Health News:CoLucid Pharmaceuticals Announces $25 Million Series B Financing for Advancement of First-in-Class Migraine Compound 2Health News:CoLucid Pharmaceuticals Announces $25 Million Series B Financing for Advancement of First-in-Class Migraine Compound 3Health News:CoLucid Pharmaceuticals Announces $25 Million Series B Financing for Advancement of First-in-Class Migraine Compound 4Health News:New System Devised To Guide Doctors Treating Patients With Symptomatic Myocardial Bridging 2Health News:New System Devised To Guide Doctors Treating Patients With Symptomatic Myocardial Bridging 3Health News:New System Devised To Guide Doctors Treating Patients With Symptomatic Myocardial Bridging 4Health News:Texas Oncology Urges Texans to ‘Save Your Skin:' Outsmart the Sun and Prevent Skin Cancer 2Health News:Texas Oncology Urges Texans to ‘Save Your Skin:' Outsmart the Sun and Prevent Skin Cancer 3Health News:Texas Oncology Urges Texans to ‘Save Your Skin:' Outsmart the Sun and Prevent Skin Cancer 4Health News:National Medical Association Hosts the 2008 Annual Convention and Scientific Assembly 2Health News:Janssen Announces Launch of Authorized Generic for RISPERDAL(R) 2Health News:Janssen Announces Launch of Authorized Generic for RISPERDAL(R) 3Health News:Janssen Announces Launch of Authorized Generic for RISPERDAL(R) 4
... Record organizes communication and chart information ... practitioners. It also manages orders, procedures, ... that traditionally rely on many people ... With Microsoft Outlook integration, HealthMatics EMR ...
... Description PANALOK is a fully-absorbable soft ... (polylactic acid) material and provides fixation ... The X-ray transparent anchor retains strength ... and eventually absorbs leaving no permanent ...
... The Bio-Anchor implant is molded from Poly ... absorption rate to insure secure fixation throughout ... eliminates implant removal complications because it is ... be over-drilled. The ribbed, press-fit anchor ...
... just got better. How can one of ... Simply by becoming more convenient to use ... arthroscopic. The TwinFix Suture Anchor with Needles ... unique, convenient and timesaving anchor inserter and ...
Medicine Products: